Nanotechnology approaches for global infectious diseases

Area of Science:

• Infectious Diseases
• Nanotechnology
• Drug Delivery

Background:

• Infectious diseases are a significant global cause of illness and death.
• Malaria, tuberculosis, and HIV present major treatment challenges due to ongoing transmission and high mortality.
• Current treatments face limitations including poor bioavailability and patient non-adherence.

Purpose of the Study:

• To review the global burden of infectious diseases.
• To highlight the potential of nanotechnology in improving infectious disease treatments.
• To summarize progress and future directions for nanomedicine in infectious disease control.

Main Methods:

• Literature review of infectious disease burden.
• Analysis of nanotechnology applications in drug formulation.
• Discussion of nanocarrier-based vaccine development.

Main Results:

• Nanocarriers can enhance bioavailability and target drug accumulation for infectious disease therapies.
• Nanotechnology can overcome challenges like drug resistance and toxicity.
• Nanocarriers show promise for effective vaccine delivery systems.

Conclusions:

• Nanotechnology presents a promising approach to combat infectious diseases.
• Formulating drugs and vaccines in nanocarriers can significantly improve treatment outcomes.
• Further research and development in nanomedicine are crucial for global health impact.